Quince Therapeutics, Inc. (QNCX)
(Delayed Data from NSDQ)
$1.67 USD
+0.01 (0.60%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $1.68 +0.01 (0.60%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Quince Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
QNCX 1.67 +0.01(0.60%)
Will QNCX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QNCX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for QNCX
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for ...
QNCX: JMP Securities Initiates Coverage with Market Outperform Rating | QNCX Stock News
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Quince Therapeutics (QNCX) Receives Positive Coverage with Strong Growth Potential
Quince Therapeutics initiated with an Outperform at Citizens JMP